Cafepharma Today

October 21 2024 - Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on
Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on
Novo Nordisk's oral diabetes drug cuts heart-related risks by 14% in study
Roche reports topline data from trial of Vabysmo for diabetic macular edema
Gilead, Merck say HIV combo could be weekly, oral HIV drug
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Radiopharma CDMO Nucleus lays out plan to triple manufacturing capacity, add 100 jobs
Fierce Pharma
Monday, October 21, 2024 - 11:44pm
tags:
CDMOs, Nucleus RadioPharma, cancer
Is Intuitive the Coca-Cola of Surgical Robotics?
Medical Devices and Diagnostics Industry
Monday, October 21, 2024 - 11:41pm
tags:
Medtech, Intuitive Surgical, robotic surgery, Da Vinci Surgical System
Sanofi moves ahead with CD&R deal for stake in consumer business
BioPharma Dive
Monday, October 21, 2024 - 11:40pm
tags:
Sanofi, Opella, consumer health, M&A
Activist investor Starboard sets its sights on J&J spinout Kenvue
Fierce Pharma
Monday, October 21, 2024 - 11:38pm
tags:
Starboard, Pfizer, JNJ, Kenvue, activist investors
Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on
Fierce Pharma
Monday, October 21, 2024 - 11:34am
tags:
Takeda, layoffs, Massachusetts
Nurix Therapeutics’ NX-5948 shows promise in Waldenstrom’s macroglobulinaemia trial
Clinical Trials Arena
Monday, October 21, 2024 - 11:32am
tags:
Nurix Therapeutics, NX-5948, clinical trials, Waldenström’s macroglobulinemia
Endospan hits enrolment milestone in aortic arch stent trial
Clinical Trials Arena
Monday, October 21, 2024 - 11:21am
tags:
Endospan, Medtech, clinical trials, stent grafts, aortic arch disease
Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases
Cambridge University
Monday, October 21, 2024 - 11:05am
tags:
GSK, Cambridge University, kidney disease, respiratory disease
Lykos accepts FDA’s view that reviving rejected MDMA therapy’s fortunes requires fresh phase 3 trial
Fierce Biotech
Monday, October 21, 2024 - 9:48am
tags:
Lykos Therapeutics, MDMA, FDA
Roche reports topline data from trial of Vabysmo for diabetic macular edema
Clinical Trials Arena
Monday, October 21, 2024 - 9:44am
tags:
Roche, Vabysmo, diabetic macular edema
Septerna plans $158M IPO to fund clinical readouts for GPCR pipeline
Fierce Biotech
Monday, October 21, 2024 - 9:42am
tags:
Septerna, IPOs, GPCRs
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout
Reuters
Monday, October 21, 2024 - 9:41am
tags:
Catalent, Alessandro Maselli, Novo Holdings, M&A
Novo Nordisk's oral diabetes drug cuts heart-related risks by 14% in study
Reuters
Monday, October 21, 2024 - 9:39am
tags:
Novo Nordisk, Rybelsus, cardiovascular events
FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage
Pharma Voice
Monday, October 21, 2024 - 9:37am
tags:
FDA, GLP-1 agonists, Ozempic, Wegovy, Novo Nordisk, drug shortages, Eli Lilly, Zepbound
Gilead, Merck say HIV combo could be weekly, oral HIV drug
Pharmaphorum
Monday, October 21, 2024 - 9:35am
tags:
Gilead Sciences, Merck, HIV, antiretrovirals, clinical trials, islatravir, Sunleca
Supernus’ depression drug improved symptoms in two hours in Phase IIa study
Clinical Trials Arena
Sunday, October 20, 2024 - 10:24pm
tags:
Supernus Pharmaceuticals, SPN-820, major depressive disorder, clinical trials
Astellas nabs class-first FDA approval for CLDN18.2 gastric cancer med Vyloy
Fierce Pharma
Sunday, October 20, 2024 - 10:22pm
tags:
Astellas, FDA, Vyloy, gastric cancer
Sanofi reaches deal on terms of sale of consumer health arm, say French government sources
Reuters
Sunday, October 20, 2024 - 10:18pm
tags:
Sanofi, M&A, Opella, consumer health
Medtronic MiniMed 600 and 700 Series Pump Recall Dubbed FDA Class I
Medical Devices and Diagnostics Industry
Sunday, October 20, 2024 - 10:17pm
tags:
Medtech, Medtronic, device recalls, MiniMed 600, MiniMed 700, FDA
Gilead withdraws bladder cancer drug in US after failed trial
Reuters
Friday, October 18, 2024 - 11:35am
tags:
Gilead Sciences, Trodelvy, bladder cancer, clinical trials

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

Informa Connect’s Trade and Channel Strategies
Drug Channels
AI Does Not Make It Easy
In the Pipeline
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
Drug Channels
Accelerated Approval: What Is It Accomplishing?
In the Pipeline
Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline
Induced Proximity, in the Lab and in the Clinic
In the Pipeline
If Plan Sponsors Are So Unhappy with Their PBMs’ Transparency, Why Won’t They Change the Model?
Drug Channels
Half-Full and Half-Empty AI Glasses
In the Pipeline
As MFP Approaches, Transparency Is More Important Than Ever
Drug Channels

Latest Jobs

Account Manager-Orlando, FL-Ophthalmics
Maitland, Florida, 32794
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Alafaya, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Union Park, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Bunker Hill Village, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Phoenix, AZ-Oncology
Paradise Valley, Arizona, 85253
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Pasadena, Texas, 77505
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Cloverleaf, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Gotha, Florida, 34734
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Longwood, Florida, 32791
Sun Pharmaceutical Industries, Inc.
Territory Manager - Medical Dermatology, Richmond VA
Richmond
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information